An invalid vocabulary is selected. Please change it in the options.
Title Creditssort descending Start date - Expiration date
NCCN Pharmacy Updates: New Developments in the Management of Metastatic Bladder Cancer 1.00 01/26/2021 - 12:00am to 07/04/2021 - 12:00am
NCCN Guidelines® Insights - Melanoma: Cutaneous, Version 2.2021 1.00 04/10/2021 - 12:00am to 04/10/2022 - 12:00am
NCCN Guidelines® Insights - Colorectal Cancer Screening, Version 2.2020 1.00 10/10/2020 - 12:00am to 10/10/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas 1.00 11/19/2020 - 12:00am to 11/17/2021 - 12:00am
NCCN Guidelines® Insights - T-Cell Lymphomas, Version 1.2021 1.00 11/10/2020 - 12:00am to 11/10/2021 - 12:00am
Recorded Presentation from the New NCCN Guidelines for Pediatric Cancers: Advancements in the Management of Pediatric Acute Lymphoblastic Leukemia 1.00 01/27/2021 - 12:00am to 01/27/2022 - 12:00am
Genetic Testing in Patients with Breast Cancer: Who Should Get Tested? 1.00 03/15/2021 - 12:00am to 03/15/2022 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Bladder Cancer 1.00 10/08/2020 - 12:00am to 10/08/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Melanoma 1.00 11/30/2020 - 12:00am to 11/30/2021 - 12:00am
HER2-Positive Breast Cancer: A Guide Through An Evolving Treatment Landscape 1.50 02/25/2021 - 12:00am to 02/25/2022 - 12:00am
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance 1.75 07/02/2020 - 12:00am to 07/02/2021 - 12:00am
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy 2.00 12/18/2020 - 12:00am to 12/18/2021 - 12:00am
AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm 2.50 12/18/2020 - 12:00am to 12/18/2021 - 12:00am

Pages